Article Details
Retrieved on: 2018-02-20 13:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Finally, <b>Renaissance Technologies</b> LLC lifted its position in Oramed Pharmaceuticals by 12.7% during the fourth quarter. <b>Renaissance Technologies</b> LLC now owns 93,500 shares of the biotechnology company's stock valued at $842,000 after buying an additional 10,500 shares during the period.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here